Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer

Julie Brahmer, Karen L. Reckamp, Paul Baas, Lucio Crinò, Wilfried E.E. Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E. Vokes, Esther Holgado, David Waterhouse, Neal Ready, Justin Gainor, Osvaldo Arén Frontera, Libor Havel, Martin Steins, Marina C. Garassino, Joachim G. Aerts, Manuel Domine, Luis Paz-AresMartin Reck, Christine Baudelet, Christopher T. Harbison, Brian Lestini, David R. Spigel

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences